Snail or Go-Back: which antiseptic technique kills more germs?
NCT ID NCT04002245
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested two different techniques for applying alcoholic antiseptic to healthy skin before placing an IV device. Researchers measured how many germs were on the skin before and after each method in 132 healthy volunteers. The goal was to gather initial data to plan a larger, more definitive study on which technique works best.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- alcoholic antiseptic
- What this could lead to
- If successful, this study could help determine the best way to apply antiseptic before placing an IV, potentially reducing infection risk in hospitals.
- What could go wrong
- This is a very early pilot study with only 132 healthy volunteers, not patients. It does not test actual infection rates, so results may not translate to real-world hospital settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH CARE UTILIZATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ISFI Pellegrin - CHU de Bordeaux
Bordeaux, 33000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better healthcare access save hearts after prison?
- Can a simple Self-Affirmation exercise boost COVID testing?
- Can peer mentors help stop HIV transmission from mother to child?
- Can a coordinated care program boost quality of life for cancer patients facing social hardships?
- Wiping out medical debt may boost mental health and access to care
- New program aims to help breast cancer survivors get better follow-up care